Cortexyme

Developer of therapeutics to treat neurodegenerative diseases

placeSan Francisco, California, United States calendar_todayFounded 2012 groups21 employees language cortexyme.com

Innovation

11 patent families (4 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 834 times.

YearFilings
20161
20174
20184
20195
20205
20216
20225
20233
20241

Investor mix

13 investors on record.

Investor typeCountShare
Other / undisclosed13100%
Coming soon